Monte Rosa Therapeutics, Inc

Senior Research Associate, Compound Manager

Job Locations CH-Basel
ID
2026-1223
Category
Chemistry
Position Type
Regular Full-Time
Min
CHF 90,000.00/Yr.
Max
USD $105,000.00/Yr.

Overview

At Monte Rosa Therapeutics, we’re excited to seek a dedicated Compound Manager to join our team. You’ll play a pivotal role within our Compound Management Team, working closely with colleagues to deliver compounds in a variety of formats for the Screening Teams. Your expertise will directly support the characterization of innovative small molecule glue-based degraders and drive the advancement of our expanding pipeline. If you’re passionate about collaboration, innovation, and making a real impact in scientific discovery, we’d love to meet you.

Responsibilities

  • Provide Compound Management support for storage, retrieval and distribution of compounds
  • Manually produce solutions from milligram amounts of neat compounds
  • Prepare compound plates using a robotic system
  • Track various transfer steps through the use of a software
  • Maintain lab and ensure equipment is clean and safe

Qualifications

  • 3+ years of applicable experience within Chemistry laboratory setting
  • BSc/MSc degree in Chemistry or in a related scientific discipline is preferred; experienced Chemielaborant with relevant laboratory experience will also be considered.
  • Hands-on experience in Sample Management, with a good understanding of relevant processes and workflows.
  • Experience with LIMS and laboratory automation.
  • Flexible and adaptable, with the ability to respond effectively to changing priorities and deadlines.
  • Excellent attention to detail and a high level of accuracy in laboratory work and documentation.
  • Strong organizational, communication, and problem-solving skills, with the ability to work effectively both independently and as part of a team.

Fluent in English, both written and spoken

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed